Discover a revolutionary approach to cancer screening with the Galleri® Multi-Cancer Early Detection Test. This advanced blood test detects over 50 types of cancer, many of which lack standard screening options, allowing for early intervention and better outcomes.
The Galleri test uses next-generation sequencing to analyze cell-free DNA (cfDNA) isolated from peripheral whole blood. By identifying DNA methylation patterns unique to cancer, the test provides high sensitivity with a low false-positive rate. It is designed to supplement, not replace, routine cancer screenings like colonoscopies and mammograms.
Key Features:
Cancers shed DNA fragments into the bloodstream as they grow. These fragments act like unique “fingerprints” for different cancer types. The Galleri test identifies these fingerprints and predicts the Cancer Signal Origin (CSO) to guide your healthcare provider in determining next steps for diagnosis.
The Galleri test is not suitable for everyone. Individuals who fall into the following categories should not undergo testing:
We recommend repeating this test on a yearly basis for proactive health monitoring.
Start your journey towards early cancer detection. Contact Reverse Gravity Medical Aesthetics to learn more about the Galleri test and schedule your appointment.